StockVS

Chiron Real Estate Inc. (XRN) 주식 분석

부동산

Chiron Real Estate Inc.

$36.87

$-0.55 (-1.47%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

Chiron Real Estate Inc. (XRN) operates as a net-lease medical real estate investment trust focused on acquiring healthcare facilities and leasing them to physician groups and regional or national healthcare systems. This business model positions the company within the Real Estate sector, specifically the REIT - Healthcare Facilities industry, which typically offers stable cash flows derived from long-term leases with creditworthy medical tenants. The entity currently maintains a market capitalization of $937.02M, reports an annual revenue of $148.06M, and employs a workforce of 30 individuals. These valuation and revenue figures indicate that Chiron Real Estate Inc. has established itself as a mid-cap entity within the specialized healthcare infrastructure market, reflecting a significant asset base relative to its small employee count.

재무 건전성

The company generated revenue of $148.06M over the trailing twelve months, while reporting a net income of $-12,116,000 and an EBITDA of $91.58M, highlighting a distinct gap between operating profitability and bottom-line earnings driven by interest expenses and other costs. Despite the negative net income, the entity demonstrated strong operational cash generation with free cash flow reaching $66.62M, which provides substantial financial flexibility to service debt obligations and fund potential acquisitions without relying on external financing. The gross margin stands at 100.0%, consistent with the net-lease model where the majority of facility costs are passed to tenants, while the operating margin of 25.1% reflects efficient management of the underlying real estate assets before interest and taxes. However, the profit margin is negative at -3.9%, indicating that non-operating expenses significantly impact the bottom line in this specific reporting period. On the liquidity side, the company holds $15.19M in cash against total debt of $667.29M, resulting in a debt-to-equity ratio of 125.89 that suggests a highly leveraged balance sheet typical for leveraged buyout-style REITs. The current ratio of 1.75 indicates that the company possesses sufficient short-term assets to cover its short-term liabilities, ensuring adequate immediate liquidity. Finally, the return on equity is -1.3% and the return on assets is 1.9%, revealing that while asset utilization is positive, the high leverage and current net loss are suppressing the returns generated for shareholders.

밸류에이션 평가

Valuation metrics for Chiron Real Estate Inc. present a complex picture, with a trailing P/E ratio listed as N/A due to the recent net loss, while the forward P/E is calculated at -56.88, implying that future earnings expectations are currently not sufficient to justify the current share price under traditional multiples. The price-to-book ratio is 1.18, suggesting that the market values the company slightly above its book value, which is a standard premium for real estate firms with tangible assets. Alternatively, the price-to-sales ratio of 6.33 and an EV/EBITDA of 13.67 provide a clearer view of valuation relative to revenue and operating cash flow, indicating the market is willing to pay a significant premium for the company's revenue base. In terms of trading range, the stock has a 52-week high of $39.93 and a 52-week low of $29.05, and without a specific current price provided in the data, the valuation context relies on these bounds to gauge historical volatility. The beta of 1.20 indicates that the stock's price volatility is 20% higher than the broader market, reflecting the cyclical nature of real estate and the specific risks associated with the healthcare sector.

Growth & Income

The company achieved a revenue growth rate of 9.2% year-over-year, whereas earnings growth is N/A due to the current negative net income, implying that top-line expansion is occurring even as profitability remains suppressed by high interest costs or one-time expenses. Regarding income distribution, the dividend yield is reported at 8.7% with a payout ratio of 1114.3%, which is unsustainable given the negative earnings and indicates that dividends are likely being funded from cash reserves or debt rather than retained profits. Given the payout ratio exceeding 100% and the negative net income, the company is not currently growing earnings to fund dividends, and the high yield reflects a return on capital that may be at risk if cash flows deteriorate. The overall growth and income profile is characterized by strong revenue expansion and significant cash flow generation, contrasted sharply by a high-yield dividend that lacks a sustainable earnings base and a leveraged capital structure that constrains equity returns.

동종업체 비교

Chiron Real Estate Inc. (XRN) 은(는) REIT - 의료 시설 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
Chiron Real Estate Inc. XRN $530.22M N/A
Welltower Inc. WELL $153.98B 105.4
Ventas, Inc. VTR $42.96B 160.7
Omega Healthcare Investors, Inc. OHI $15.07B 23.4

REIT - 의료 시설 산업 평균 PER은 60.2배입니다. Chiron Real Estate Inc.의 PER은 N/A입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

Chiron Real Estate Inc. 소개

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011, incorporated in Maryland and is based in Bethesda, United States.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$530.22M
PER
N/A
52주 최고가
$39.93
52주 최저가
$29.05
평균 거래량
156.86K
베타
1.14
배당수익률
15.54%

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NYSE
국가
United States
직원 수
30